Results 11 to 20 of about 327,270 (275)

Genome-wide analysis of somatic noncoding mutation patterns and mitochondrial heteroplasmic shift in type B1 and B2 thymomas. [PDF]

open access: yesJ Pathol
Abstract Type B1 and B2 thymomas are lymphocyte‐rich malignant tumours with few somatic mutations in protein‐coding regions of the nuclear genome; nonetheless, noncoding regions remain uncharacterized. Here, we developed a method to isolate pure thymoma cells from lymphocyte‐rich tissues, and then performed genome‐wide deep sequencing. The total number
Fujikura K   +10 more
europepmc   +2 more sources

Viral infection in thymoma and thymic tumors with autoimmune diseases

open access: yesThoracic Cancer, 2021
A thymoma is a type of thymic tumor which is rarely malignant that is frequently reported in adult patients. A number of thymoma‐related immune disorders are observed including autoimmune diseases, which suggests a strong connection between thymoma ...
Rui Chang   +3 more
doaj   +1 more source

Type B3 thymoma associated membranous nephropathy: A rare case and review of the literature

open access: yesHuman Pathology: Case Reports, 2021
Thymoma can cause several autoimmune conditions in a number of patients. Nephrotic syndrome is considered to be a rare systemic manifestation from thymic lesions.
Sakda Sathirareuangchai   +3 more
doaj   +1 more source

Expression and Diagnostic Value of NPTX1 in Thymoma Patients

open access: yesChinese Journal of Lung Cancer, 2021
Background and objective Thymomas are the most common primary malignant tumors of anterior mediastinal. However, there are no specific laboratory indicator for the diagnosis the diagnosis of thymoma. The aim of this study was to screen out a tumor marker
Xin DU   +4 more
doaj   +1 more source

Analysis of Gene Variation in Thymoma by Microarray

open access: yesChinese Journal of Lung Cancer, 2020
Background and objective Thymoma is the most common malignant tumor in anterior mediastinum, and its specific pathogenesis is still unclear. This limits the study of targeted drugs for thymoma.
Lijun WANG, Lei YU, Xin DU, Chengyu HUO
doaj   +1 more source

Thymoma-Related Paraneoplastic Syndrome Mimicking Reactive Arthritis

open access: yesMedicina, 2021
Background and Objectives: Thymomas are associated with a high frequency of paraneoplastic manifestations. Paraneoplastic syndrome (PNS) with thymoma presents a challenge to clinicians because of the need to decipher the association between the ...
Chang-Hung Liao   +4 more
doaj   +1 more source

Microscopic thymoma [PDF]

open access: yesInteractive CardioVascular and Thoracic Surgery, 2006
Microscopic thymoma was first described in 1976 and remains in the latest WHO classification (2004). It defines an epithelial proliferation, with
Lara, Chalabreysse   +3 more
openaire   +2 more sources

Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma

open access: yesThoracic Cancer, 2023
Background This study aimed to examine the treatment and prognosis of patients with type B2 + B3 thymoma and compare it with those patients with type B2 and B3 thymoma. Methods We conducted a retrospective analysis of the results of 39 patients with type
Ke Zhao   +13 more
doaj   +1 more source

Thymoma metastatic to liver and pancreas: case report and review of the literature [PDF]

open access: yes, 2017
A 71-year-old man presented with a thymic mass involving the superior vena cava. A mediastinoscopical biopsy initially suggested a diagnosis of type A thymoma.
Blandamura, Stella   +4 more
core   +1 more source

Cyclosporine is a potential curative treatment option for advanced thymoma

open access: yesExperimental Hematology & Oncology, 2017
Background Thymectomy can effectively cure most thymoma patients; however, patients with advanced thymoma typically require chemotherapy, which is associated with limited efficacy in this context.
Yusuke Isshiki   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy